Omega Funds

General contacts
Investor type

PE / VC

Founded

2004

AUM

$1 600 M

Location

Boston, Massachusetts, United States

Investment Ticket

$10-50 m

Investment Stage

Series B Series A Seed Pre-seed Late Stage (Series C+)

Region of investment

North America Europe

ESG Focus

Impact investor
Investor profile last updated: 16 August, 2026

Profile

Omega Funds is a venture capital firm based in Boston, Massachusetts, and Geneva, Switzerland, focusing on the future of medicine. They are known for their strategic investments in fields such as oncology, immunology, rare diseases, and precision medicine. Their team consists of experienced professionals dedicated to helping entrepreneurs and founders increase their odds of success by leveraging their extensive network and commitments to transformative medicinal solutions. They aim to invest in exceptional founders and impactful products, with a strong emphasis on fostering successful public listings and acquisitions.

Omega Funds invests in a variety of sectors within the healthcare and life sciences industries, supporting early-stage to late-stage companies primarily in North America and Europe. They have participated in multiple funds, including Omega Fund IV through Omega Fund VIII, demonstrating significant capital commitments in these areas. They focus on strategic partnerships to bring impactful products and platforms to market.

Notable investments by Omega Funds include companies that have achieved key milestones such as public listings and acquisitions, significantly impacting the healthcare industry. They have helped bring 54 products to market, showcasing their influence and effectiveness in the medical investment landscape.

Industry

MedTech AI Software Robotics Pharmaceuticals Medical Devices Media and Entertainment Healthcare Services Gaming Foodtech Food and Beverage Fintech Financial Services Consumer Services (B2C) Consumer Products Biotechnology Life Sciences HealthTech

Omega Funds Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region 		Size AUM Launch date
Omega Fund VII
Venture Capital (VC)
Healthcare Services
Life Sciences
Seed
Series A
North America
Europe
$5-10 m
$650 M
December 2021

Contacts

Name
Title
Email
Social Networks
avatar
Vincent Ossipow Partner at Omega Funds
Partner at Omega Funds
v•••@•••
LinkedIn
avatar
Bernard Davitian Partner
Partner
b•••@•••
LinkedIn
Upgrade to see contacts
avatar
4hzeoKWJgLaNYUZQ 4hzeoKWJgLaNYUZQ
4hzeoKWJgLaNYUZQ
[email protected]
linkedin twitter
avatar
4hzeoKWJgLaNYUZQ 4hzeoKWJgLaNYUZQ
4hzeoKWJgLaNYUZQ
[email protected]
linkedin twitter
avatar
4hzeoKWJgLaNYUZQ 4hzeoKWJgLaNYUZQ
4hzeoKWJgLaNYUZQ
[email protected]
linkedin twitter
Investment-team contacts for Omega Funds — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Omega Funds

Omega Funds is a venture capital and private equity firm. It backs companies at Series B, Series A, Seed, Pre-seed and Late Stage (Series C+), writing tickets of $10-50 m.
Omega Funds is located in Boston, Massachusetts, United States.
Omega Funds was founded in 2004.
Omega Funds invests in companies and startups in MedTech, AI, Software, Robotics, Pharmaceuticals, Medical Devices, Media and Entertainment, Healthcare Services, Gaming, Foodtech, Food and Beverage, Fintech, Financial Services, Consumer Services (B2C), Consumer Products, Biotechnology, Life Sciences, HealthTech.
Omega Funds invests in companies and startups in North America, Europe.
Omega Funds invests in companies and startups at Series B, Series A, Seed, Pre-seed, Late Stage (Series C+).
Omega Funds usually invests $10-50 m on average.
Omega Funds has around $1 600m assets under management.
Omega Funds last fund was created/launched in 2021-12-20
Yes, Omega Funds is impact investor.
Omega Funds can be reached through its website omegafunds.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Omega Funds — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Omega Funds directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.